Tizanidine Tablet
Product Images NDC 67296-2209

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 67296-2209). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Molecular Structure (Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 01)

Chemical structure of Tizanidine hydrochloride, showing its molecular arrangement with chlorine, nitrogen, sulfur atoms, and associated rings, consistent with its active pharmaceutical ingredient form.*

FDA Label Image

Figure-1 (Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 02)

A line graph showing plasma Tizanidine concentration (ng/mL) over time (hours) from dosing. The graph compares 4 mg Tizanidine tablets and capsules taken with and without food, with four different curves representing each condition. Concentration peaks within the first few hours and then declines over a 24-hour period.*

FDA Label Image

Figure 3 (Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 03)

A line graph showing the improvement in Ashworth Score over 6 hours post-dose for 16 mg tizanidine, 8 mg tizanidine, and placebo groups. The vertical axis measures improvement in Ashworth Score, the horizontal axis shows hours post-dose, and error bars indicate variability for each group at different times.*

FDA Label Image

Figure 4 (Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 04)

A line chart depicting improvement in Ashworth Score over time for two groups: tizanidine (mean dose 28.8 mg) and placebo. The x-axis marks study time points: End of Titration (Week 3), End of Maintenance (Week 7), and Endpoint (Last Observation Carried Forward). Data points include mean improvement values with error bars representing variability.*

FDA Label Image

Logo (Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 05)

FDA Label Image

Container Label (Tizanidine tablets 2 mg)

Label for Tizanidine Tablets USP 2 mg, showing the active ingredient strength as 2 mg. The label states it contains 150 tablets and includes storage instructions to keep between 20° to 25°C (68° to 77°F). Manufactured by Unichem Laboratories Ltd. in India and for Unichem Pharmaceuticals (USA), Inc. The label includes a warning that Tizanidine tablets are not interchangeable with Tizanidine capsules.*

FDA Label Image

Container Label (Tizanidine tablets 4 mg)

Label for Tizanidine Tablets, USP 4 mg, oral tablet form. The label includes the NDC 29300-169-15, a quantity of 150 tablets, and a warning that Tizanidine tablets are not interchangeable with capsules. It specifies storage at 20° to 25°C and contains a barcode. The product is manufactured by Unichem Laboratories Ltd. in India and for Unichem Pharmaceuticals (USA), Inc., East Brunswick, NJ.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.